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Background: Maternal mortality remains a major public health issue worldwide, with persistent high rates
prevailing principally in underdeveloped countries. The objective of this study was to determine the risk factors for
severe maternal morbidity and near miss (SMM/NM) in pregnant and postpartum women at the maternity ward of
the Dom Malan Hospital, Petrolina, in northeastern Brazil.
Methods: A retrospective, cohort study was conducted to evaluate the sociodemographic and obstetric
characteristics of the women. Patients who remained hospitalized at the end of the study period were excluded.
Risk ratios (RR) and their respective 95% confidence intervals (95% CI) were calculated as a measure of relative risk.
Hierarchical multiple logistic regression was also performed. Two-tailed p-values were used for all the tests and the
significance level adopted was 5%.
Results: A total of 2,291 pregnant or postpartum women receiving care between May and August, 2011 were
included. The frequencies of severe maternal morbidity and near miss were 17.5% and 1.0%, respectively. Following
multivariate analysis, the factors that remained significantly associated with an increased risk of SMM/NM were a
Cesarean section in the current pregnancy (OR: 2.6; 95% CI: 2.0 – 3.3), clinical comorbidities (OR: 3.4; 95% CI: 2.5 – 4.4),
having attended fewer than six prenatal visits (OR: 1.1; 95% CI: 1.01 – 1.69) and the presence of the third delay (i.e.
delay in receiving care at the health facility) (OR: 13.3; 95% CI: 6.7 – 26.4).
Conclusions: The risk of SMM/NM was greater in women who had been submitted to a Cesarean section in the
current pregnancy, in the presence of clinical comorbidities, fewer prenatal visits and when the third delay was present.
All these factors could be minimized by initiating a broad debate on healthcare policies, introducing preventive
measures and improving the training of the professionals and services providing obstetric care.
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Maternal mortality remains a major public health issue
worldwide. Although reducing maternal mortality is part
of the international commitment referred to as the
Millennium Development Goals and despite the fact that
the latest studies have suggested a trend towards a de-
crease in its incidence in recent years [1-3], rates remain* Correspondence: katzleila@gmail.com
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reproduction in any medium, provided the orhigh, with an unequal global distribution in which 99%
of cases occur in underdeveloped countries [4-7].
Studies on the physiopathology of pregnancy, child-
birth and the postpartum have revealed a wide spectrum
of clinical conditions in women, ranging from a healthy
pregnancy to the other extreme of maternal death.
Severe maternal morbidity forms part of this range of
clinical conditions and begins with the occurrence of a
complication that could progress to maternal death.
Another extremely critical group that merits particular
emphasis concerns cases that are referred to as near
miss which is a more severe condition than severe ma-
ternal morbidity [8,9].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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patients who survive an experience of severe maternal
morbidity or near miss has been increasing, since the
study of such patients may permit extrapolations to be
made on the quality of care provided to women during
pregnancy and in the postpartum [10-29]. In the largest
population-based study conducted to this date, which
was carried out in the Netherlands and involved 371,021
women, the authors described a frequency of near miss
of 0.7% of all deliveries performed in that country [10].
In 2009, the World Health Organization (WHO) de-
veloped an instrument to standardize the definition of
cases of severe maternal morbidity and near miss with
the aim of evaluating the quality of obstetric care. This
instrument uses an association of three major groups of
criteria: management complexity; signs, symptoms or
specific clinical entities; and organ dysfunction [30].
Identifying both the clinical factors associated with
states of maternal morbidity and the delays that occur in
the sequence of the obstetric care provided may permit
early intervention to be made within the process that
leads a healthy pregnant or postpartum woman to the
other extreme in this chain of events, i.e. to maternal
death [31-40].
Methods
A retrospective cohort study was conducted in the mater-
nity ward of the Dom Malan Hospital, a reference center in
obstetric care for high risk pregnancies in the São Francisco
Valley region. Located in the town of Petrolina in the state
of Pernambuco, it is the only reference center for high
complexity obstetric and neonatal care within the region
covered by the Integrated Development Program for the
São Francisco Valley region of northeastern Brazil.
Sample size was calculated using the OpenEpi software
program, version 2.3.1, after data had been collected from
the first 600 women. These data indicated a rate of severe
maternal morbidity/near miss of 20% for women who had
been submitted to a Cesarean section in their previous
pregnancy compared to 15% in women who had had a
vaginal delivery. Considering a significance level of 95%,
relative precision of 20% and an expected loss of 20%,
sample size was established as 2,240 patients. This num-
ber was rounded up to 2,290, anticipating an initial pro-
grammed data collection period of four months.
A total of 2,291 pregnant or postpartum women, con-
secutively admitted to the Dom Malan Hospital between
May and August 2011, were included in the study.
Those who had not yet been discharged within the study
period or whose medical records were unavailable were
excluded from the study. Since the data were collected
after the patients had been discharged from hospital, the
institute’s internal review board was asked to waive the
requirement for informed consent.The study was initiated only after approval of the
protocol had been granted by the internal review board
of the Federal University of the São Francisco Valley
(UNIVASF) in approval letter # 0039.0.441.000-11.
Severe maternal morbidity (SMM) and near miss (NM)
are defined as the presence of at least one of the crite-
ria adopted by the World Health Organization (WHO) in
2009 [30]. For the purpose of this study, we chose to
evaluate severe maternal morbidity and near miss mater-
nal mortality as a group. The term SMM/NM is used to
describe patients who have suffered severe maternal
morbidity and/or a near miss. The sociodemographic and
obstetric characteristics of the women were evaluated, as
well as the presence of any of the “three delays”. Co-
morbidities were considered present when there were
preexisting medical conditions or chronic conditions
recognized during pregnancy that could negatively affect
its course for example hypertension, diabetes, maternal
HIV infection or heart disease.
The “three delays” model was originally conceived to
evaluate cases of maternal death, [11] and was later
adopted for the study of cases of near miss. The first
delay consists of a situation in which the patient or her
family fails to recognize the severity of her situation and
delays the decision to seek care. The second delay refers
to the patient’s inability to gain access to a healthcare
service after having made the decision to seek care. The
third delay concerns the inability of the healthcare pro-
fessionals to provide patients with adequate or timely
care, or a lack of basic infrastructure within the health-
care service to meet the demands made on it [11].
Prior to initiating data collection, three researchers in-
volved were trained to identify the delays through the ana-
lysis of information from medical charts. Three observers
assessed the files and evaluated the presence of delays,
and if there were different opinions the decision of two of
the reviewers prevailed. Regarding the prenatal care first
delay was considered present if prenatal care was absent,
if the number of prenatal care visits was below the recom-
mendations of Brazil Ministry of Health, or if prenatal care
was started after the first trimester. A first delay was con-
sidered present also, if medical chart informed that despite
the presence of conditions that indicate the need of me-
dical attention, the patient did not seek for care. A second
delay was considered if there was information that the pa-
tient or her family tried to reach medical assistance but
did not have access. Third delays were identified according
to data recorded on medical charts regarding the manage-
ment given to each case. This management was compared
to protocols provided by the Brazilian Federation of
Societies of Obstetrics and Gynecology (FEBRASGO),
by FIGO (International Federation of Gynecology and
Obstetrics) and the World Health Organization (WHO)
and judged that a third delay was present if there was an
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conduction.
The statistical analysis was performed using the Epi-Info
software program, version 7 (Atlanta, GA, USA). Frequen-
cies were calculated for the categorical variables, and
means and their respective standard deviations were cal-
culated for the numerical variables. A bivariate analysis
was conducted to verify the existence of differences bet-
ween the groups using Pearson’s chi-square test or Fisher’s
exact test, as appropriate. All p-values were two-tailed and
a significance level of 5% was adopted. To determine the
strength of the association, risk ratios (RR) and their 95%
confidence intervals (95% CI) were calculated.
All the variables evaluated in the bivariate analysis were
included in the multiple logistic regression analysis to
identify those most strongly associated with SMM/NM,
thus determining the adjusted risk. The causal model was
adopted and the variables were divided into blocks, the
more distal factors being the biological and socioeconomic
variables (level 1), followed by the reproductive, prenatal
and lifestyle variables (level 2) and, finally, the variables
concerning the presence of comorbidities, whether the
patient had been submitted to a Cesarean section and the
presence of the three delays (level 3), these being con-
sidered the variables closest to the end-point. Stepwise
logistic regression was performed, with the variables asso-
ciated with the end-point at a significance level of 20%
remaining in the model. The procedure was then repeated
with these variables for a significance level of 5%, and a
final regression was then performed to determine the
adjusted risk of SMM/NM for each one of the variables
significantly associated with the end-point at a significance
level of 5%.
Results
A total of 2,291 patient charts were analyzed, with three
maternal deaths being identified. In the other 2,288 charts,
400 cases of severe maternal morbidity (17.5%) were
found, as well as 24 records containing criteria indicative
of a near miss (1%).
The mean age of the patients with SMM/NM was 25.4 ±
7.1 years compared to 24.2 ± 6.5 years for the other patients
(p = 0.001). The patients with SMM/NM had a mean of
8.2 years of schooling and a median of two pregnancies,
while median parity was one. Mean gestational age at ad-
mission was 35.4 ± 6.1 weeks, with deliveries occurring at a
mean of 36.5 ± 5.7 weeks. The median number of prenatal
visits attended by the patients with SMM/NM was 6.0.
Mean birth weight of the newborn infants of the women
with SMM/NM was lower (2,811 ± 855.8 grams) compared
to the infants of the women without these complications
(3,130 ± 586.6 grams) (p < 0.0001) (Table 1).
In the bivariate analysis, statistically significant associa-
tions were found between the following characteristicsand SMM/NM: history of a previous Cesarean section
(RR: 1.43; 95% CI: 1.13 – 1.81; p = 0.003), cesarean section
in the current pregnancy (RR: 1.99; 95% CI: 1.71-2.28;
p < 0.0001), presence of the third delay (RR: 4.0; 95%
CI: 3.27 – 4.97; p < 0.0001), presence of the second delay
(RR: 3.4; 95% CI: 2.41 – 4.70; p < 0.0001), presence of clin-
ical comorbidities in general (RR: 2.7; 95% CI: 2.31 – 3.26;
p < 0.0001) and of chronic arterial hypertension in particu-
lar (RR: 6.78; 95% CI: 2.26 – 20.33; p < 0.0001) (Table 2).
After multivariate analysis, the following characteristics
remained significantly associated with severe maternal
morbidity and/or near miss: a Cesarean section in the
current pregnancy (OR: 2.6; 95% CI: 2.00 – 3.35), the pre-
sence of any comorbidity (OR: 3.4; 95% CI: 2.57 – 4.40),
presence of the third delay (OR: 13.3; 95% CI: 6.73 –
26.37) and having attended fewer than six prenatal visits
(OR: 1.13; 95% CI: 1.01 – 1.69) (Table 3).
Discussion
In the present study, the frequency of severe maternal
morbidity and near miss was high compared to that found
in developed countries [2,10], considering that 17.5% of
the women were found to have at least one of the condi-
tions defining SMM and 1% had criteria indicative of a
near miss during the period evaluated [10,15,23-28]. A re-
cent systematic literature review published in 2012 on this
subject indicated a prevalence that ranged from 0.04% to
15% depending on the criteria used to define it [1].
During the study period, three maternal deaths oc-
curred in the Dom Malan Hospital, revealing a relatively
low near miss/maternal mortality ratio (1.8), in agree-
ment with the findings of a nationwide study published
in 2012 [32], but in conflict with the results found in
studies conducted in developed countries [1,15,18,36],
including a study carried out in the Netherlands that re-
ported a ratio of one death for every 53 cases of near
miss [10].
In addition to the variation in the actual incidence of
SMM and NM in the different regions, the numbers
may also be affected by the different definitions used for
these conditions, which may explain the substantial va-
riations in the frequency of SMM/NM found in the
literature. The present study used the criteria proposed
by the World Health Organization in 2009 [30], whereas
other studies have used different defining criteria such
as those established by Mantel or Waterstone [22,26,27].
Some studies have reported the extreme limits of re-
productive age as being a condition associated with a
greater risk of SMM/NM [12,26,29]; however, this was
not found in the present study. It is possible that the re-
gional characteristics of the population may have influ-
enced the results. There were relatively few women at
the extreme limits of reproductive age in this study, with
women under 15 years of age accounting for only 3.5%




(n = 400) (n = 1888)
Age in years (mean/SD) 25.4 7.1 24.2 6.5 0.001
Schooling in years (mean/SD) 8.2 3.4 8.0 3.1 0.24
Number of pregnancies (Median/IQR) 2.0 1-3 2.0 1-3 0.18
Number of deliveries (Median/IQR) 1.0 0-2 1.0 0-2 0.12
Gestational age at admission in weeks (mean/SD) 35.4 6.1 35.7 8.3 0.43
Gestational age at delivery in weeks (mean/SD) 36.5 5.7 36.1 8.1 0.38
Number of prenatal visits (Median/IQR) 6.0 4-8 6.0 5-8 0.22
Birth weight in grams (mean/SD) 2.811 855.8 3.130 586.6 <0.0001
*Mann Whitney test; SD: standard deviation; IQR: interquartile range.
Pacheco et al. BMC Pregnancy and Childbirth 2014, 14:91 Page 4 of 8
http://www.biomedcentral.com/1471-2393/14/91of the sample, while those over 35 years of age ac-
counted for 7% of the sample. This may have limited the
power of the study to evaluate these groups of women.
Gestational age at the time of delivery being within the
definitions of prematurity, 1st minute Apgar score < 7 and
birth weight < 2,500 grams in patients with SMM/NM
may reflect a need to intervene in the natural progres-
sion of diseases associated with unfavorable outcomes,
particularly in the case of hypertensive syndromes
[20,21,25,28,32]. The fact that the Dom Malan Hospital
is the only service in the region with neonatal and ob-
stetric intensive care units (ICU) explains the large
number of premature infants and pregnant women with
comorbidities or obstetric complications in whom early
delivery is a common form of management. In the
present study, 12.7% of the patients suffered hyperten-
sive complications, which may in part explain these
findings.
Evaluating the factors associated with the occurrence of
SMM/NM, multiple logistic regression analysis showed
that only the variables having been submitted to a
Cesarean section in the current pregnancy, presence of co-
morbidity, having attended fewer than six prenatal visits
and the presence of the third delay significantly increased
this risk.
In relation to having been submitted to a Cesarean sec-
tion in the current pregnancy, the extreme importance of
this issue merits particular emphasis in view of the high
and continually rising rates of this intervention in women
in Brazil, reaching 52.0% of deliveries according to data
published by the Ministry of Health in 2010 [41]. In
the present study, having been submitted to a Cesarean
section in the current pregnancy was associated with a
2.5-fold greater risk of experiencing severe maternal mor-
bidity or a near miss. This finding is in agreement with
data published from other studies [25,38]. In a study in-
volving approximately 370,000 Dutch women, a relative
risk of 5.2 was found for progression to near miss inpatients who had been submitted to a Cesarean section in
a previous pregnancy and of 5.9 for women submitted to
an elective Cesarean section in the current pregnancy
[10]. It appears reasonable to speculate that the intrinsic
morbidity associated with being submitted to this proce-
dure, including the higher risk of infection, hemorrhage,
thromboembolism or complications, justifies the results
found.
Being aware of the sequence of events that may occur
during the course of a normal pregnancy leading to the
other extreme of maternal death contributes towards un-
derstanding the association found between the presence
of comorbidities and SMM/NM [8]. The results of the
present study show a significant increase in the risk of
progression to SMM/NM in women with a history of
arterial hypertension prior to becoming pregnant. This
finding is in agreement with reports from various similar
studies in which hypertensive syndromes during preg-
nancy were more common not only in patients with
SMM/NM but also in those cases that resulted in mater-
nal death [2,20,21,25,28,32]. In a study conducted in a ter-
tiary maternity hospital in the city of Campinas in the
Brazilian state of São Paulo, a rate of hypertension of 96%
was found in patients with severe maternal morbidity [23].
Other studies have concluded that hypertensive syn-
dromes remain a significant cause of mortality in pregnant
women, constituting the principal cause of direct obstetric
maternal mortality in various locations [19,20].
The median number of prenatal visits attended by the
patients with SMM/NM in the present study was in
accordance with the recommendations of the Brazilian
Ministry of Health, i.e. at least six visits [42]. This fin-
ding reflects the increase in prenatal coverage at primary
healthcare level in Brazil, probably as a result of the ex-
pansion in the teams working in the family health stra-
tegy [38]. On the other hand, 14% of the patients seen at
the Dom Malan Hospital at the time of this study had
attended fewer than six prenatal visits, a condition that
Table 2 Factors associated with severe maternal morbidity (SMM) and near miss (NM) in the bivariate analysis
Variable SMM/NM RR 95% CI p-value
Present (n = 400)
n %
< 4 years of schooling
Yes 32 20.5 1.21 0.88-1.69 0.23*
No 303 16.8
Age < 15 years
Yes 8 14.5 0.83 0.43-1.58 0.56*
No 391 17.5
Age > 35 years
Yes 34 21.5 1.27 0.93-1.74 0.14*
No 365 17.1
Skin color black
Yes 15 22.7 1.31 0.83-2.06 0.25*
No 385 17.3
No partner
Yes 184 17.9 1.05 0.88- 1.25 0.60*
No 216 17.1
<6 prenatal visits
Yes 136 18.2 1.13 0.93-1.38 0.20*
No 202 16.0
Number of pregnancies≤ 4
Yes 83 18.4 1.09 0.88-1.37 0.40*
No 302 16.8
Covered by the national health system
Yes 274 17.0 0.90 0.74-1.09 0.31*
No 126 18.7
Prior Cesarean section
Yes 67 22.9 1.43 1.13-1.81 0.003*
No 290 16.0
Cesarean section in current pregnancy
Yes 181 29.7 1.99 1.71-2.28 <0.0001*
No 219 13.1
Presence of any comorbidity
Yes 145 36.6 2.74 2.31-3.26 <0.0001*
No 255 13.5
Chronic arterial hypertension #
Yes 73 52.1 6.78 2.26-20.33 <0.0001*
No 3 7.7
Diabetes ##
Yes 6 26.1 2.73 0.86-8.72 0.08**
No 4 9.5
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Table 2 Factors associated with severe maternal morbidity (SMM) and near miss (NM) in the bivariate analysis
(Continued)
Maternal obesity ###
Yes 1 50.0 1.78 0.13-10.13 0.08 **
No 4 9.5
Smoking
Yes 10 12.8 1.25 0.42-3.73 0.68**
No 4 10.3
First delay
Yes 119 18.4 1.07 0.88-1.30 0.48*
No 281 17.1
Second delay
Yes 16 57.1 3.36 2.41-4.70 <0.0001*
No 380 17.0
Third delay
Yes 38 53.5 4.04 3.27-4.97 <0.0001*
No 362 16.2
*Chi-square test **Fisher’s exact test. #Data available for only 179 women. ##Data available for only 65 women. ###Data available for only 44 women.
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bidity, as shown in a study conducted in the city of
Niteroi, Rio de Janeiro, in 2009 in which 30% of the
women identified with severe maternal morbidity ac-
cording to the WHO criteria had not attended any pre-
natal visits [28].
Another fact that merits attention is that only 5.7% of
the patients admitted to the Dom Malan Hospital were re-
ferred from primary healthcare, with the majority of the
patients seeking the service spontaneously (69.2%).
Although the influence of the different healthcare levels
(primary, secondary and tertiary) was not analyzed in the
present study, these results show a greater frequency of
patient-related delay (the first of the delays in the “three
delays model”) in the group of women with SMM/NM
[11]. However, following multivariate analysis, this variable
did not remain significantly associated with the end-point.
On the other hand, the delay associated with healthcare
professionals, either in recognizing the situation of risk
or in intervening in a timely manner (the third delay),Table 3 Conditions associated with severe maternal morbidit
analysis
Variable Coefficient Sta
Cesarean section in current pregnancy 0.95
Presence of comorbidities 1.20
< 6 prenatal visits 0.27
Third delay 2.59remained significantly associated with a greater risk of
developing SMM/NM, a finding that is in agreement with
other recent studies [10,12,39,43]. The association bet-
ween the third delay and SMM/NM is understandable,
since the timely recognition of conditions that could de-
velop unfavorably during pregnancy, childbirth or in the
postpartum, and the provision of the necessary care in an
opportune manner constitute the latest tool for interrupt-
ing the process that leads to SMM/NM. When all the pre-
vious measures fail and the woman is found to be in a
situation of risk, the third delay may then contribute sig-
nificantly to her progression to severe maternal morbidity.
Based on our review of the Pubmed, Embase, Lilacs/
SciELO, Scopus and Cochrane databases, to the best of
our knowledge this study is the first to be conducted on
the subject of SMM/NM in the São Francisco Valley re-
gion of northeastern Brazil. This is important, bearing in
mind that the indicators of maternal mortality are unsat-
isfactory in northeastern Brazil, specifically in the region
in which this study was conducted, [41,42] whiley (SMM) and near miss (NM) following multivariate
ndard error Odds ratio 95% CI p-value
0.13 2.6 2.00 – 3.35 <0.0001
0.13 3.4 2.57- 4.40 <0.0001
0.13 1.13 1.01-1.69 0.04
0.34 13.3 6.73-26.37 <0.0001
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contribute towards implementing important changes in
this scenario.
Furthermore, few international studies have evaluated
the factors associated with the presence of severe mater-
nal morbidity or near miss. At national level, this study
is one of the first to evaluate this matter, thus adding
significantly to the current knowledge available on the
subject. The results found may help establish public
healthcare policies and strategies aimed at tackling the
issue of maternal morbidity and mortality.
The fact that this is a retrospective study in which the
data were collected from patient records constitutes a
limitation, since the charts may have been filled out
inaccurately. Some of the variables collected initially and
planned to be included in the causal theoretical model
were excluded from the analysis because the data were
unavailable, including such variables as, for example, the
patient’s weight, how labor began, the association between
the outcome and assisted reproduction, or the patient’s
family income. Other variables which are risk factors
for cesarean section and SMM/NM such as obstructed
labour, placenta praevia, chorioamnionitis and placental
abruption, were not available for analysis which also im-
poses a limitation to the study. Nevertheless, a large num-
ber of patients were included, guaranteeing the power of
the sample to show relevant differences for the different
risk factors investigated.
A future prospective study should be conducted to ac-
quire further information on the profile of these patients
and on the risk factors for SMM/NM, including a quali-
tative evaluation of the situation of patients affected by
these events. Findings from such a study would contrib-
ute towards clarifying some of the gaps that remain in
current knowledge. Listening to the women who have
experienced events severe enough to be classified as
SMM or NM will certainly form an important part of
future studies.
Conclusions
These results show that severe maternal morbidity and
near miss occurred in a significant number of patients at
the Dom Malan Hospital between May and August 2011.
The principal risk factors associated with these conditions
were the presence of clinical comorbidities, having had a
Cesarean section, having attended fewer than six prenatal
visits and the presence of delays associated with the
healthcare professionals.
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